nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP2D6—Lomustine—brain cancer	0.0927	0.182	CbGbCtD
Iloperidone—CYP1A2—Carmustine—brain cancer	0.0917	0.181	CbGbCtD
Iloperidone—CYP2D6—Hydroxyurea—brain cancer	0.0702	0.138	CbGbCtD
Iloperidone—CYP3A4—Temozolomide—brain cancer	0.0693	0.136	CbGbCtD
Iloperidone—CYP3A4—Lomustine—brain cancer	0.0589	0.116	CbGbCtD
Iloperidone—CYP2E1—Etoposide—brain cancer	0.047	0.0926	CbGbCtD
Iloperidone—CYP3A5—Etoposide—brain cancer	0.0365	0.0719	CbGbCtD
Iloperidone—CYP1A2—Etoposide—brain cancer	0.0272	0.0535	CbGbCtD
Iloperidone—HTR1D—meninx—brain cancer	0.0178	0.0738	CbGeAlD
Iloperidone—HTR1D—dura mater—brain cancer	0.0164	0.0679	CbGeAlD
Iloperidone—CYP3A4—Etoposide—brain cancer	0.0142	0.028	CbGbCtD
Iloperidone—HTR2C—choroid plexus—brain cancer	0.0138	0.0572	CbGeAlD
Iloperidone—DRD3—telencephalic ventricle—brain cancer	0.00726	0.0301	CbGeAlD
Iloperidone—HTR1D—trigeminal nerve—brain cancer	0.00704	0.0292	CbGeAlD
Iloperidone—HTR2A—choroid plexus—brain cancer	0.00691	0.0287	CbGeAlD
Iloperidone—HRH1—nose—brain cancer	0.00533	0.0221	CbGeAlD
Iloperidone—DRD1—telencephalic ventricle—brain cancer	0.0052	0.0216	CbGeAlD
Iloperidone—HTR7—vein—brain cancer	0.00507	0.021	CbGeAlD
Iloperidone—HTR1D—cranial nerve—brain cancer	0.00502	0.0208	CbGeAlD
Iloperidone—Hyperaemia—Carmustine—brain cancer	0.00474	0.0302	CcSEcCtD
Iloperidone—HTR6—ganglion—brain cancer	0.00435	0.018	CbGeAlD
Iloperidone—HTR1D—telencephalic ventricle—brain cancer	0.00408	0.0169	CbGeAlD
Iloperidone—HTR2C—telencephalic ventricle—brain cancer	0.00404	0.0167	CbGeAlD
Iloperidone—HTR7—cranial nerve—brain cancer	0.004	0.0166	CbGeAlD
Iloperidone—HTR7—pons—brain cancer	0.00395	0.0164	CbGeAlD
Iloperidone—HTR2A—trigeminal nerve—brain cancer	0.0035	0.0145	CbGeAlD
Iloperidone—HTR2A—cerebellar cortex—brain cancer	0.00348	0.0144	CbGeAlD
Iloperidone—HTR1A—telencephalic ventricle—brain cancer	0.0034	0.0141	CbGeAlD
Iloperidone—HTR7—telencephalic ventricle—brain cancer	0.00325	0.0135	CbGeAlD
Iloperidone—DRD1—ganglion—brain cancer	0.00324	0.0134	CbGeAlD
Iloperidone—Nystagmus—Procarbazine—brain cancer	0.0032	0.0204	CcSEcCtD
Iloperidone—HTR2A—vein—brain cancer	0.00316	0.0131	CbGeAlD
Iloperidone—DRD2—telencephalic ventricle—brain cancer	0.00307	0.0127	CbGeAlD
Iloperidone—Cisapride—CYP2C9—brain cancer	0.00294	0.418	CrCbGaD
Iloperidone—Blepharitis—Hydroxyurea—brain cancer	0.00288	0.0183	CcSEcCtD
Iloperidone—Faecal incontinence—Carmustine—brain cancer	0.00283	0.0181	CcSEcCtD
Iloperidone—Faecal incontinence—Temozolomide—brain cancer	0.00274	0.0175	CcSEcCtD
Iloperidone—Lethargy—Lomustine—brain cancer	0.00267	0.017	CcSEcCtD
Iloperidone—Amenorrhoea—Procarbazine—brain cancer	0.0026	0.0166	CcSEcCtD
Iloperidone—HTR1D—ganglion—brain cancer	0.00254	0.0105	CbGeAlD
Iloperidone—HTR2C—ganglion—brain cancer	0.00251	0.0104	CbGeAlD
Iloperidone—HTR2A—cranial nerve—brain cancer	0.00249	0.0103	CbGeAlD
Iloperidone—HTR2A—pons—brain cancer	0.00246	0.0102	CbGeAlD
Iloperidone—Gefitinib—EGFR—brain cancer	0.00214	0.305	CrCbGaD
Iloperidone—HTR1A—ganglion—brain cancer	0.00212	0.00877	CbGeAlD
Iloperidone—Paranoia—Carmustine—brain cancer	0.0021	0.0134	CcSEcCtD
Iloperidone—Gynaecomastia—Procarbazine—brain cancer	0.00205	0.013	CcSEcCtD
Iloperidone—HTR2A—telencephalic ventricle—brain cancer	0.00203	0.0084	CbGeAlD
Iloperidone—HTR7—ganglion—brain cancer	0.00202	0.00839	CbGeAlD
Iloperidone—HTR1D—blood vessel—brain cancer	0.00202	0.00837	CbGeAlD
Iloperidone—Amenorrhoea—Hydroxyurea—brain cancer	0.00201	0.0128	CcSEcCtD
Iloperidone—Stomatitis—Lomustine—brain cancer	0.00196	0.0125	CcSEcCtD
Iloperidone—Gefitinib—CYP2C9—brain cancer	0.00195	0.278	CrCbGaD
Iloperidone—DRD2—ganglion—brain cancer	0.00191	0.00793	CbGeAlD
Iloperidone—Menorrhagia—Temozolomide—brain cancer	0.00187	0.0119	CcSEcCtD
Iloperidone—Extrapyramidal disorder—Temozolomide—brain cancer	0.00184	0.0117	CcSEcCtD
Iloperidone—HTR2A—pineal body—brain cancer	0.00176	0.00729	CbGeAlD
Iloperidone—HTR7—endothelium—brain cancer	0.00174	0.00723	CbGeAlD
Iloperidone—Lethargy—Procarbazine—brain cancer	0.00169	0.0108	CcSEcCtD
Iloperidone—HTR6—telencephalon—brain cancer	0.00168	0.00696	CbGeAlD
Iloperidone—Endocrine disorder—Temozolomide—brain cancer	0.00167	0.0106	CcSEcCtD
Iloperidone—HTR7—blood vessel—brain cancer	0.00161	0.00667	CbGeAlD
Iloperidone—HTR1A—hindbrain—brain cancer	0.0016	0.00665	CbGeAlD
Iloperidone—Breast pain—Temozolomide—brain cancer	0.00158	0.0101	CcSEcCtD
Iloperidone—Amenorrhoea—Temozolomide—brain cancer	0.00157	0.01	CcSEcCtD
Iloperidone—HTR7—hindbrain—brain cancer	0.00153	0.00636	CbGeAlD
Iloperidone—ADRA1A—hindbrain—brain cancer	0.00148	0.00613	CbGeAlD
Iloperidone—Gait disturbance—Carmustine—brain cancer	0.00147	0.00934	CcSEcCtD
Iloperidone—Infection—Carboplatin—brain cancer	0.00146	0.0093	CcSEcCtD
Iloperidone—DRD2—hindbrain—brain cancer	0.00145	0.00601	CbGeAlD
Iloperidone—Gait disturbance—Temozolomide—brain cancer	0.00142	0.00903	CcSEcCtD
Iloperidone—Leukopenia—Lomustine—brain cancer	0.00141	0.00898	CcSEcCtD
Iloperidone—DRD1—brainstem—brain cancer	0.00141	0.00583	CbGeAlD
Iloperidone—Renal failure acute—Hydroxyurea—brain cancer	0.00139	0.00887	CcSEcCtD
Iloperidone—Urinary incontinence—Carmustine—brain cancer	0.00138	0.0088	CcSEcCtD
Iloperidone—Urinary incontinence—Temozolomide—brain cancer	0.00133	0.00851	CcSEcCtD
Iloperidone—Pollakiuria—Procarbazine—brain cancer	0.00132	0.00844	CcSEcCtD
Iloperidone—Gynaecomastia—Carmustine—brain cancer	0.00128	0.00816	CcSEcCtD
Iloperidone—Dry eye—Temozolomide—brain cancer	0.00128	0.00814	CcSEcCtD
Iloperidone—Infection—Lomustine—brain cancer	0.00128	0.00813	CcSEcCtD
Iloperidone—HTR2A—ganglion—brain cancer	0.00126	0.00523	CbGeAlD
Iloperidone—DRD1—telencephalon—brain cancer	0.00125	0.00518	CbGeAlD
Iloperidone—Stomatitis—Procarbazine—brain cancer	0.00125	0.00794	CcSEcCtD
Iloperidone—Epistaxis—Procarbazine—brain cancer	0.00121	0.00769	CcSEcCtD
Iloperidone—Body temperature increased—Carboplatin—brain cancer	0.00116	0.0074	CcSEcCtD
Iloperidone—Breast disorder—Hydroxyurea—brain cancer	0.00116	0.0074	CcSEcCtD
Iloperidone—DRD4—brain—brain cancer	0.00112	0.00464	CbGeAlD
Iloperidone—Amnesia—Carmustine—brain cancer	0.0011	0.00704	CcSEcCtD
Iloperidone—HTR1D—brainstem—brain cancer	0.0011	0.00458	CbGeAlD
Iloperidone—Nasal congestion—Temozolomide—brain cancer	0.0011	0.00702	CcSEcCtD
Iloperidone—HTR2C—brainstem—brain cancer	0.00109	0.00453	CbGeAlD
Iloperidone—HTR2A—endothelium—brain cancer	0.00109	0.00451	CbGeAlD
Iloperidone—DRD3—head—brain cancer	0.00109	0.0045	CbGeAlD
Iloperidone—CYP3A7—endocrine gland—brain cancer	0.00108	0.00446	CbGeAlD
Iloperidone—Amnesia—Temozolomide—brain cancer	0.00107	0.00681	CcSEcCtD
Iloperidone—Thirst—Temozolomide—brain cancer	0.00105	0.00672	CcSEcCtD
Iloperidone—HTR6—head—brain cancer	0.00104	0.00433	CbGeAlD
Iloperidone—Dysuria—Hydroxyurea—brain cancer	0.00104	0.00661	CcSEcCtD
Iloperidone—Arrhythmia—Procarbazine—brain cancer	0.00103	0.00654	CcSEcCtD
Iloperidone—Body temperature increased—Lomustine—brain cancer	0.00102	0.00647	CcSEcCtD
Iloperidone—Weight increased—Hydroxyurea—brain cancer	0.00101	0.00644	CcSEcCtD
Iloperidone—HTR2A—blood vessel—brain cancer	0.001	0.00416	CbGeAlD
Iloperidone—Mouth ulceration—Etoposide—brain cancer	0.001	0.00637	CcSEcCtD
Iloperidone—DRD3—central nervous system—brain cancer	0.000991	0.00411	CbGeAlD
Iloperidone—Affect lability—Temozolomide—brain cancer	0.000987	0.00629	CcSEcCtD
Iloperidone—HTR1D—telencephalon—brain cancer	0.000979	0.00406	CbGeAlD
Iloperidone—HTR2C—telencephalon—brain cancer	0.00097	0.00402	CbGeAlD
Iloperidone—Stomatitis—Hydroxyurea—brain cancer	0.000965	0.00615	CcSEcCtD
Iloperidone—HTR2A—hindbrain—brain cancer	0.000956	0.00397	CbGeAlD
Iloperidone—HTR6—central nervous system—brain cancer	0.000954	0.00396	CbGeAlD
Iloperidone—Mood swings—Temozolomide—brain cancer	0.00095	0.00606	CcSEcCtD
Iloperidone—Hypokalaemia—Carmustine—brain cancer	0.000945	0.00602	CcSEcCtD
Iloperidone—Tremor—Procarbazine—brain cancer	0.000936	0.00597	CcSEcCtD
Iloperidone—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000936	0.00597	CcSEcCtD
Iloperidone—Dehydration—Temozolomide—brain cancer	0.000933	0.00595	CcSEcCtD
Iloperidone—Anaemia—Procarbazine—brain cancer	0.000924	0.00589	CcSEcCtD
Iloperidone—HTR1A—brainstem—brain cancer	0.00092	0.00381	CbGeAlD
Iloperidone—Hypokalaemia—Temozolomide—brain cancer	0.000913	0.00582	CcSEcCtD
Iloperidone—SIGMAR1—telencephalon—brain cancer	0.000913	0.00379	CbGeAlD
Iloperidone—Breast disorder—Temozolomide—brain cancer	0.000907	0.00578	CcSEcCtD
Iloperidone—DRD1—midbrain—brain cancer	0.000896	0.00372	CbGeAlD
Iloperidone—Leukopenia—Procarbazine—brain cancer	0.000894	0.0057	CcSEcCtD
Iloperidone—HTR7—brainstem—brain cancer	0.000879	0.00365	CbGeAlD
Iloperidone—CYP2D6—hindbrain—brain cancer	0.000871	0.00361	CbGeAlD
Iloperidone—Arthralgia—Procarbazine—brain cancer	0.000851	0.00542	CcSEcCtD
Iloperidone—Myalgia—Procarbazine—brain cancer	0.000851	0.00542	CcSEcCtD
Iloperidone—ADRA1A—brainstem—brain cancer	0.000848	0.00352	CbGeAlD
Iloperidone—Dry mouth—Procarbazine—brain cancer	0.000832	0.0053	CcSEcCtD
Iloperidone—DRD2—brainstem—brain cancer	0.000831	0.00345	CbGeAlD
Iloperidone—Cardiac failure—Etoposide—brain cancer	0.000823	0.00524	CcSEcCtD
Iloperidone—Confusional state—Procarbazine—brain cancer	0.000822	0.00524	CcSEcCtD
Iloperidone—HTR1A—telencephalon—brain cancer	0.000816	0.00338	CbGeAlD
Iloperidone—Oedema—Procarbazine—brain cancer	0.000815	0.0052	CcSEcCtD
Iloperidone—Dysuria—Temozolomide—brain cancer	0.000811	0.00517	CcSEcCtD
Iloperidone—Infection—Procarbazine—brain cancer	0.00081	0.00516	CcSEcCtD
Iloperidone—Angiopathy—Hydroxyurea—brain cancer	0.000806	0.00514	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Temozolomide—brain cancer	0.000806	0.00514	CcSEcCtD
Iloperidone—Pollakiuria—Temozolomide—brain cancer	0.000801	0.00511	CcSEcCtD
Iloperidone—Erectile dysfunction—Temozolomide—brain cancer	0.000799	0.00509	CcSEcCtD
Iloperidone—Tachycardia—Procarbazine—brain cancer	0.000796	0.00507	CcSEcCtD
Iloperidone—Weight increased—Temozolomide—brain cancer	0.000789	0.00503	CcSEcCtD
Iloperidone—DRD3—brain—brain cancer	0.000787	0.00326	CbGeAlD
Iloperidone—Weight decreased—Temozolomide—brain cancer	0.000784	0.005	CcSEcCtD
Iloperidone—HTR7—telencephalon—brain cancer	0.00078	0.00323	CbGeAlD
Iloperidone—Stomatitis—Carmustine—brain cancer	0.00078	0.00497	CcSEcCtD
Iloperidone—DRD1—head—brain cancer	0.000777	0.00322	CbGeAlD
Iloperidone—Nausea—Lomustine—brain cancer	0.000763	0.00486	CcSEcCtD
Iloperidone—Hypotension—Procarbazine—brain cancer	0.000762	0.00486	CcSEcCtD
Iloperidone—HTR2C—medulla oblongata—brain cancer	0.000762	0.00316	CbGeAlD
Iloperidone—HTR6—brain—brain cancer	0.000757	0.00314	CbGeAlD
Iloperidone—Stomatitis—Temozolomide—brain cancer	0.000754	0.0048	CcSEcCtD
Iloperidone—ADRA1A—telencephalon—brain cancer	0.000752	0.00312	CbGeAlD
Iloperidone—SIGMAR1—pituitary gland—brain cancer	0.000743	0.00308	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000743	0.00474	CcSEcCtD
Iloperidone—DRD2—telencephalon—brain cancer	0.000737	0.00306	CbGeAlD
Iloperidone—Paraesthesia—Procarbazine—brain cancer	0.000732	0.00467	CcSEcCtD
Iloperidone—Hepatobiliary disease—Temozolomide—brain cancer	0.000731	0.00466	CcSEcCtD
Iloperidone—Somnolence—Procarbazine—brain cancer	0.000725	0.00462	CcSEcCtD
Iloperidone—SIGMAR1—medulla oblongata—brain cancer	0.000717	0.00297	CbGeAlD
Iloperidone—ADRA2C—telencephalon—brain cancer	0.000717	0.00297	CbGeAlD
Iloperidone—Anaemia—Hydroxyurea—brain cancer	0.000715	0.00456	CcSEcCtD
Iloperidone—DRD1—central nervous system—brain cancer	0.000709	0.00294	CbGeAlD
Iloperidone—Connective tissue disorder—Carmustine—brain cancer	0.000706	0.0045	CcSEcCtD
Iloperidone—HTR1D—midbrain—brain cancer	0.000703	0.00292	CbGeAlD
Iloperidone—Fatigue—Procarbazine—brain cancer	0.000703	0.00448	CcSEcCtD
Iloperidone—HTR2C—midbrain—brain cancer	0.000696	0.00289	CbGeAlD
Iloperidone—Leukopenia—Hydroxyurea—brain cancer	0.000692	0.00441	CcSEcCtD
Iloperidone—Urinary tract disorder—Temozolomide—brain cancer	0.000685	0.00437	CcSEcCtD
Iloperidone—Connective tissue disorder—Temozolomide—brain cancer	0.000682	0.00435	CcSEcCtD
Iloperidone—Urethral disorder—Temozolomide—brain cancer	0.00068	0.00434	CcSEcCtD
Iloperidone—HTR2C—spinal cord—brain cancer	0.000679	0.00282	CbGeAlD
Iloperidone—Feeling abnormal—Procarbazine—brain cancer	0.000672	0.00428	CcSEcCtD
Iloperidone—Eye disorder—Carmustine—brain cancer	0.000671	0.00428	CcSEcCtD
Iloperidone—SIGMAR1—midbrain—brain cancer	0.000656	0.00272	CbGeAlD
Iloperidone—HTR7—gonad—brain cancer	0.000651	0.0027	CbGeAlD
Iloperidone—Eye disorder—Temozolomide—brain cancer	0.000649	0.00413	CcSEcCtD
Iloperidone—Tinnitus—Temozolomide—brain cancer	0.000647	0.00412	CcSEcCtD
Iloperidone—Body temperature increased—Procarbazine—brain cancer	0.000645	0.00411	CcSEcCtD
Iloperidone—Cardiac disorder—Temozolomide—brain cancer	0.000644	0.00411	CcSEcCtD
Iloperidone—Arrhythmia—Carmustine—brain cancer	0.000642	0.00409	CcSEcCtD
Iloperidone—SIGMAR1—spinal cord—brain cancer	0.00064	0.00265	CbGeAlD
Iloperidone—Oedema—Hydroxyurea—brain cancer	0.000631	0.00402	CcSEcCtD
Iloperidone—Angiopathy—Temozolomide—brain cancer	0.00063	0.00401	CcSEcCtD
Iloperidone—Mental disorder—Carmustine—brain cancer	0.000629	0.00401	CcSEcCtD
Iloperidone—Infection—Hydroxyurea—brain cancer	0.000627	0.004	CcSEcCtD
Iloperidone—Mediastinal disorder—Temozolomide—brain cancer	0.000625	0.00399	CcSEcCtD
Iloperidone—Malnutrition—Carmustine—brain cancer	0.000625	0.00398	CcSEcCtD
Iloperidone—Nervous system disorder—Hydroxyurea—brain cancer	0.000619	0.00395	CcSEcCtD
Iloperidone—HTR7—medulla oblongata—brain cancer	0.000613	0.00254	CbGeAlD
Iloperidone—HTR1D—head—brain cancer	0.00061	0.00253	CbGeAlD
Iloperidone—Mental disorder—Temozolomide—brain cancer	0.000608	0.00388	CcSEcCtD
Iloperidone—Malnutrition—Temozolomide—brain cancer	0.000604	0.00385	CcSEcCtD
Iloperidone—HTR2C—head—brain cancer	0.000604	0.0025	CbGeAlD
Iloperidone—Stomatitis—Etoposide—brain cancer	0.000603	0.00384	CcSEcCtD
Iloperidone—DRD2—pituitary gland—brain cancer	0.0006	0.00249	CbGeAlD
Iloperidone—Vision blurred—Carmustine—brain cancer	0.000589	0.00376	CcSEcCtD
Iloperidone—HTR1A—midbrain—brain cancer	0.000586	0.00243	CbGeAlD
Iloperidone—Tremor—Carmustine—brain cancer	0.000586	0.00373	CcSEcCtD
Iloperidone—Asthenia—Procarbazine—brain cancer	0.000585	0.00373	CcSEcCtD
Iloperidone—Hepatobiliary disease—Etoposide—brain cancer	0.000585	0.00373	CcSEcCtD
Iloperidone—ADRA2C—pituitary gland—brain cancer	0.000584	0.00242	CbGeAlD
Iloperidone—HRH1—telencephalon—brain cancer	0.000582	0.00242	CbGeAlD
Iloperidone—Anaemia—Carmustine—brain cancer	0.000578	0.00368	CcSEcCtD
Iloperidone—Agitation—Carmustine—brain cancer	0.000574	0.00366	CcSEcCtD
Iloperidone—ADRA2A—telencephalon—brain cancer	0.000572	0.00237	CbGeAlD
Iloperidone—HTR1A—spinal cord—brain cancer	0.000572	0.00237	CbGeAlD
Iloperidone—Vision blurred—Temozolomide—brain cancer	0.000569	0.00363	CcSEcCtD
Iloperidone—Tremor—Temozolomide—brain cancer	0.000566	0.00361	CcSEcCtD
Iloperidone—ADRA2C—medulla oblongata—brain cancer	0.000563	0.00234	CbGeAlD
Iloperidone—DRD1—brain—brain cancer	0.000563	0.00234	CbGeAlD
Iloperidone—Dyspnoea—Hydroxyurea—brain cancer	0.000563	0.00359	CcSEcCtD
Iloperidone—Somnolence—Hydroxyurea—brain cancer	0.000561	0.00358	CcSEcCtD
Iloperidone—HTR7—midbrain—brain cancer	0.00056	0.00232	CbGeAlD
Iloperidone—CYP2E1—telencephalon—brain cancer	0.00056	0.00232	CbGeAlD
Iloperidone—Leukopenia—Carmustine—brain cancer	0.00056	0.00357	CcSEcCtD
Iloperidone—Anaemia—Temozolomide—brain cancer	0.000558	0.00356	CcSEcCtD
Iloperidone—Diarrhoea—Procarbazine—brain cancer	0.000558	0.00356	CcSEcCtD
Iloperidone—HTR1D—central nervous system—brain cancer	0.000557	0.00231	CbGeAlD
Iloperidone—Agitation—Temozolomide—brain cancer	0.000555	0.00354	CcSEcCtD
Iloperidone—HTR2C—central nervous system—brain cancer	0.000551	0.00229	CbGeAlD
Iloperidone—Urinary tract disorder—Etoposide—brain cancer	0.000548	0.0035	CcSEcCtD
Iloperidone—HTR2A—brainstem—brain cancer	0.000548	0.00227	CbGeAlD
Iloperidone—HTR7—spinal cord—brain cancer	0.000547	0.00227	CbGeAlD
Iloperidone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000545	0.00347	CcSEcCtD
Iloperidone—Urethral disorder—Etoposide—brain cancer	0.000544	0.00347	CcSEcCtD
Iloperidone—Fatigue—Hydroxyurea—brain cancer	0.000544	0.00347	CcSEcCtD
Iloperidone—Vertigo—Temozolomide—brain cancer	0.000543	0.00346	CcSEcCtD
Iloperidone—Leukopenia—Temozolomide—brain cancer	0.000541	0.00345	CcSEcCtD
Iloperidone—Dizziness—Procarbazine—brain cancer	0.000539	0.00344	CcSEcCtD
Iloperidone—Palpitations—Temozolomide—brain cancer	0.000534	0.0034	CcSEcCtD
Iloperidone—Myalgia—Carmustine—brain cancer	0.000532	0.00339	CcSEcCtD
Iloperidone—DRD2—midbrain—brain cancer	0.00053	0.0022	CbGeAlD
Iloperidone—Feeling abnormal—Hydroxyurea—brain cancer	0.00052	0.00332	CcSEcCtD
Iloperidone—Eye disorder—Etoposide—brain cancer	0.000519	0.00331	CcSEcCtD
Iloperidone—Cardiac disorder—Etoposide—brain cancer	0.000515	0.00329	CcSEcCtD
Iloperidone—ADRA2C—midbrain—brain cancer	0.000515	0.00214	CbGeAlD
Iloperidone—HTR1A—endocrine gland—brain cancer	0.000515	0.00213	CbGeAlD
Iloperidone—Confusional state—Carmustine—brain cancer	0.000514	0.00328	CcSEcCtD
Iloperidone—Myalgia—Temozolomide—brain cancer	0.000514	0.00328	CcSEcCtD
Iloperidone—Arthralgia—Temozolomide—brain cancer	0.000514	0.00328	CcSEcCtD
Iloperidone—Rash—Procarbazine—brain cancer	0.000514	0.00328	CcSEcCtD
Iloperidone—Dermatitis—Procarbazine—brain cancer	0.000514	0.00327	CcSEcCtD
Iloperidone—Oedema—Carmustine—brain cancer	0.00051	0.00325	CcSEcCtD
Iloperidone—HTR1A—head—brain cancer	0.000508	0.00211	CbGeAlD
Iloperidone—SIGMAR1—cerebellum—brain cancer	0.000507	0.0021	CbGeAlD
Iloperidone—Infection—Carmustine—brain cancer	0.000507	0.00323	CcSEcCtD
Iloperidone—Angiopathy—Etoposide—brain cancer	0.000504	0.00321	CcSEcCtD
Iloperidone—Dry mouth—Temozolomide—brain cancer	0.000503	0.00321	CcSEcCtD
Iloperidone—ADRA2C—spinal cord—brain cancer	0.000502	0.00208	CbGeAlD
Iloperidone—Mediastinal disorder—Etoposide—brain cancer	0.0005	0.00319	CcSEcCtD
Iloperidone—CYP2D6—brainstem—brain cancer	0.000499	0.00207	CbGeAlD
Iloperidone—Body temperature increased—Hydroxyurea—brain cancer	0.000499	0.00318	CcSEcCtD
Iloperidone—Tachycardia—Carmustine—brain cancer	0.000498	0.00317	CcSEcCtD
Iloperidone—Confusional state—Temozolomide—brain cancer	0.000497	0.00317	CcSEcCtD
Iloperidone—Oedema—Temozolomide—brain cancer	0.000493	0.00314	CcSEcCtD
Iloperidone—HTR7—endocrine gland—brain cancer	0.000492	0.00204	CbGeAlD
Iloperidone—Infection—Temozolomide—brain cancer	0.00049	0.00312	CcSEcCtD
Iloperidone—HTR2A—telencephalon—brain cancer	0.000486	0.00202	CbGeAlD
Iloperidone—HTR7—head—brain cancer	0.000486	0.00201	CbGeAlD
Iloperidone—Nausea—Procarbazine—brain cancer	0.000484	0.00309	CcSEcCtD
Iloperidone—Nervous system disorder—Temozolomide—brain cancer	0.000484	0.00308	CcSEcCtD
Iloperidone—ADRA2A—gonad—brain cancer	0.000477	0.00198	CbGeAlD
Iloperidone—Hypotension—Carmustine—brain cancer	0.000477	0.00304	CcSEcCtD
Iloperidone—ADRA1A—endocrine gland—brain cancer	0.000475	0.00197	CbGeAlD
Iloperidone—ADRA1A—head—brain cancer	0.000469	0.00194	CbGeAlD
Iloperidone—ADRA2A—pituitary gland—brain cancer	0.000466	0.00193	CbGeAlD
Iloperidone—DRD2—endocrine gland—brain cancer	0.000465	0.00193	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000465	0.00296	CcSEcCtD
Iloperidone—Muscle spasms—Etoposide—brain cancer	0.000465	0.00296	CcSEcCtD
Iloperidone—HTR1A—central nervous system—brain cancer	0.000464	0.00192	CbGeAlD
Iloperidone—DRD2—head—brain cancer	0.000459	0.0019	CbGeAlD
Iloperidone—Paraesthesia—Carmustine—brain cancer	0.000458	0.00292	CcSEcCtD
Iloperidone—Dyspnoea—Carmustine—brain cancer	0.000455	0.0029	CcSEcCtD
Iloperidone—Somnolence—Carmustine—brain cancer	0.000454	0.00289	CcSEcCtD
Iloperidone—HTR1A—cerebellum—brain cancer	0.000453	0.00188	CbGeAlD
Iloperidone—Asthenia—Hydroxyurea—brain cancer	0.000453	0.00289	CcSEcCtD
Iloperidone—ADRA2A—medulla oblongata—brain cancer	0.000449	0.00186	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000449	0.00286	CcSEcCtD
Iloperidone—Anaemia—Etoposide—brain cancer	0.000447	0.00285	CcSEcCtD
Iloperidone—ADRA2C—head—brain cancer	0.000446	0.00185	CbGeAlD
Iloperidone—HTR7—central nervous system—brain cancer	0.000443	0.00184	CbGeAlD
Iloperidone—CYP2D6—telencephalon—brain cancer	0.000443	0.00184	CbGeAlD
Iloperidone—Paraesthesia—Temozolomide—brain cancer	0.000443	0.00282	CcSEcCtD
Iloperidone—HTR1D—brain—brain cancer	0.000442	0.00183	CbGeAlD
Iloperidone—Gastrointestinal disorder—Carmustine—brain cancer	0.00044	0.00281	CcSEcCtD
Iloperidone—CYP2E1—medulla oblongata—brain cancer	0.00044	0.00182	CbGeAlD
Iloperidone—Dyspnoea—Temozolomide—brain cancer	0.00044	0.0028	CcSEcCtD
Iloperidone—Somnolence—Temozolomide—brain cancer	0.000438	0.00279	CcSEcCtD
Iloperidone—HTR2C—brain—brain cancer	0.000438	0.00181	CbGeAlD
Iloperidone—Vertigo—Etoposide—brain cancer	0.000434	0.00277	CcSEcCtD
Iloperidone—HTR7—cerebellum—brain cancer	0.000433	0.0018	CbGeAlD
Iloperidone—Leukopenia—Etoposide—brain cancer	0.000433	0.00276	CcSEcCtD
Iloperidone—Diarrhoea—Hydroxyurea—brain cancer	0.000432	0.00275	CcSEcCtD
Iloperidone—ADRA1A—central nervous system—brain cancer	0.000428	0.00177	CbGeAlD
Iloperidone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000426	0.00271	CcSEcCtD
Iloperidone—Fatigue—Temozolomide—brain cancer	0.000425	0.00271	CcSEcCtD
Iloperidone—Feeling abnormal—Carmustine—brain cancer	0.00042	0.00268	CcSEcCtD
Iloperidone—DRD2—central nervous system—brain cancer	0.000419	0.00174	CbGeAlD
Iloperidone—ADRA1A—cerebellum—brain cancer	0.000418	0.00173	CbGeAlD
Iloperidone—Dizziness—Hydroxyurea—brain cancer	0.000417	0.00266	CcSEcCtD
Iloperidone—SIGMAR1—brain—brain cancer	0.000412	0.00171	CbGeAlD
Iloperidone—ADRA2A—midbrain—brain cancer	0.000411	0.0017	CbGeAlD
Iloperidone—DRD2—cerebellum—brain cancer	0.00041	0.0017	CbGeAlD
Iloperidone—ADRA2C—central nervous system—brain cancer	0.000407	0.00169	CbGeAlD
Iloperidone—Feeling abnormal—Temozolomide—brain cancer	0.000406	0.00259	CcSEcCtD
Iloperidone—HTR2A—gonad—brain cancer	0.000406	0.00168	CbGeAlD
Iloperidone—Body temperature increased—Carmustine—brain cancer	0.000403	0.00257	CcSEcCtD
Iloperidone—ADRA2A—spinal cord—brain cancer	0.000401	0.00166	CbGeAlD
Iloperidone—ADRA2C—cerebellum—brain cancer	0.000398	0.00165	CbGeAlD
Iloperidone—Rash—Hydroxyurea—brain cancer	0.000398	0.00254	CcSEcCtD
Iloperidone—Confusional state—Etoposide—brain cancer	0.000398	0.00254	CcSEcCtD
Iloperidone—Dermatitis—Hydroxyurea—brain cancer	0.000398	0.00253	CcSEcCtD
Iloperidone—HTR2A—pituitary gland—brain cancer	0.000396	0.00164	CbGeAlD
Iloperidone—CYP1A2—endocrine gland—brain cancer	0.000392	0.00163	CbGeAlD
Iloperidone—CYP2E1—spinal cord—brain cancer	0.000392	0.00163	CbGeAlD
Iloperidone—Infection—Etoposide—brain cancer	0.000392	0.0025	CcSEcCtD
Iloperidone—Body temperature increased—Temozolomide—brain cancer	0.00039	0.00248	CcSEcCtD
Iloperidone—Tachycardia—Etoposide—brain cancer	0.000385	0.00245	CcSEcCtD
Iloperidone—HTR2A—medulla oblongata—brain cancer	0.000382	0.00158	CbGeAlD
Iloperidone—CYP3A5—endocrine gland—brain cancer	0.000378	0.00157	CbGeAlD
Iloperidone—Nausea—Hydroxyurea—brain cancer	0.000375	0.00239	CcSEcCtD
Iloperidone—Hypotension—Etoposide—brain cancer	0.000369	0.00235	CcSEcCtD
Iloperidone—HTR1A—brain—brain cancer	0.000368	0.00153	CbGeAlD
Iloperidone—HRH1—endocrine gland—brain cancer	0.000367	0.00152	CbGeAlD
Iloperidone—Asthenia—Carmustine—brain cancer	0.000366	0.00233	CcSEcCtD
Iloperidone—HRH1—head—brain cancer	0.000363	0.0015	CbGeAlD
Iloperidone—ADRA2A—endocrine gland—brain cancer	0.000361	0.0015	CbGeAlD
Iloperidone—ADRA2A—head—brain cancer	0.000356	0.00148	CbGeAlD
Iloperidone—Paraesthesia—Etoposide—brain cancer	0.000354	0.00226	CcSEcCtD
Iloperidone—Asthenia—Temozolomide—brain cancer	0.000354	0.00225	CcSEcCtD
Iloperidone—CYP2E1—endocrine gland—brain cancer	0.000353	0.00146	CbGeAlD
Iloperidone—HTR7—brain—brain cancer	0.000352	0.00146	CbGeAlD
Iloperidone—Dyspnoea—Etoposide—brain cancer	0.000352	0.00224	CcSEcCtD
Iloperidone—Somnolence—Etoposide—brain cancer	0.000351	0.00224	CcSEcCtD
Iloperidone—HTR2A—midbrain—brain cancer	0.000349	0.00145	CbGeAlD
Iloperidone—Diarrhoea—Carmustine—brain cancer	0.000349	0.00223	CcSEcCtD
Iloperidone—CYP2E1—head—brain cancer	0.000348	0.00145	CbGeAlD
Iloperidone—HTR2A—spinal cord—brain cancer	0.000341	0.00141	CbGeAlD
Iloperidone—Gastrointestinal disorder—Etoposide—brain cancer	0.000341	0.00217	CcSEcCtD
Iloperidone—Fatigue—Etoposide—brain cancer	0.00034	0.00217	CcSEcCtD
Iloperidone—ADRA1A—brain—brain cancer	0.00034	0.00141	CbGeAlD
Iloperidone—Dizziness—Carmustine—brain cancer	0.000337	0.00215	CcSEcCtD
Iloperidone—Diarrhoea—Temozolomide—brain cancer	0.000337	0.00215	CcSEcCtD
Iloperidone—DRD2—brain—brain cancer	0.000333	0.00138	CbGeAlD
Iloperidone—HRH1—central nervous system—brain cancer	0.000331	0.00137	CbGeAlD
Iloperidone—Dizziness—Temozolomide—brain cancer	0.000326	0.00208	CcSEcCtD
Iloperidone—ADRA2A—central nervous system—brain cancer	0.000325	0.00135	CbGeAlD
Iloperidone—Feeling abnormal—Etoposide—brain cancer	0.000325	0.00207	CcSEcCtD
Iloperidone—ADRA2C—brain—brain cancer	0.000324	0.00134	CbGeAlD
Iloperidone—Rash—Carmustine—brain cancer	0.000322	0.00205	CcSEcCtD
Iloperidone—Dermatitis—Carmustine—brain cancer	0.000321	0.00205	CcSEcCtD
Iloperidone—CYP2E1—central nervous system—brain cancer	0.000318	0.00132	CbGeAlD
Iloperidone—ADRA2A—cerebellum—brain cancer	0.000318	0.00132	CbGeAlD
Iloperidone—Body temperature increased—Etoposide—brain cancer	0.000312	0.00199	CcSEcCtD
Iloperidone—CYP2E1—cerebellum—brain cancer	0.000311	0.00129	CbGeAlD
Iloperidone—Rash—Temozolomide—brain cancer	0.000311	0.00198	CcSEcCtD
Iloperidone—Dermatitis—Temozolomide—brain cancer	0.000311	0.00198	CcSEcCtD
Iloperidone—HTR2A—endocrine gland—brain cancer	0.000307	0.00127	CbGeAlD
Iloperidone—Nausea—Carmustine—brain cancer	0.000303	0.00193	CcSEcCtD
Iloperidone—HTR2A—head—brain cancer	0.000303	0.00126	CbGeAlD
Iloperidone—Nausea—Temozolomide—brain cancer	0.000293	0.00187	CcSEcCtD
Iloperidone—CYP3A4—endocrine gland—brain cancer	0.000284	0.00118	CbGeAlD
Iloperidone—Asthenia—Etoposide—brain cancer	0.000283	0.0018	CcSEcCtD
Iloperidone—CYP2D6—endocrine gland—brain cancer	0.00028	0.00116	CbGeAlD
Iloperidone—HTR2A—central nervous system—brain cancer	0.000276	0.00115	CbGeAlD
Iloperidone—CYP2D6—head—brain cancer	0.000276	0.00114	CbGeAlD
Iloperidone—HTR2A—cerebellum—brain cancer	0.00027	0.00112	CbGeAlD
Iloperidone—Diarrhoea—Etoposide—brain cancer	0.00027	0.00172	CcSEcCtD
Iloperidone—HRH1—brain—brain cancer	0.000263	0.00109	CbGeAlD
Iloperidone—Dizziness—Etoposide—brain cancer	0.000261	0.00166	CcSEcCtD
Iloperidone—ADRA2A—brain—brain cancer	0.000258	0.00107	CbGeAlD
Iloperidone—CYP3A4—central nervous system—brain cancer	0.000256	0.00106	CbGeAlD
Iloperidone—CYP2E1—brain—brain cancer	0.000253	0.00105	CbGeAlD
Iloperidone—CYP2D6—central nervous system—brain cancer	0.000252	0.00104	CbGeAlD
Iloperidone—Rash—Etoposide—brain cancer	0.000249	0.00159	CcSEcCtD
Iloperidone—Dermatitis—Etoposide—brain cancer	0.000249	0.00158	CcSEcCtD
Iloperidone—CYP2D6—cerebellum—brain cancer	0.000246	0.00102	CbGeAlD
Iloperidone—Nausea—Etoposide—brain cancer	0.000234	0.00149	CcSEcCtD
Iloperidone—HTR2A—brain—brain cancer	0.000219	0.00091	CbGeAlD
Iloperidone—CYP2D6—brain—brain cancer	0.0002	0.000829	CbGeAlD
Iloperidone—HTR6—Signaling Pathways—PIK3CG—brain cancer	1.65e-05	0.000189	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—PIK3CG—brain cancer	1.65e-05	0.000189	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—APC—brain cancer	1.65e-05	0.000189	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—HES1—brain cancer	1.65e-05	0.000189	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—APC—brain cancer	1.64e-05	0.000188	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—PIK3CG—brain cancer	1.64e-05	0.000188	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ENO2—brain cancer	1.63e-05	0.000187	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.63e-05	0.000187	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.62e-05	0.000187	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IRS2—brain cancer	1.61e-05	0.000185	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.6e-05	0.000184	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—HES1—brain cancer	1.6e-05	0.000184	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.59e-05	0.000183	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IRS2—brain cancer	1.59e-05	0.000182	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.59e-05	0.000182	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—APC—brain cancer	1.58e-05	0.000181	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—PIK3CG—brain cancer	1.58e-05	0.000181	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—TP53—brain cancer	1.57e-05	0.000181	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.57e-05	0.000181	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—BSG—brain cancer	1.57e-05	0.00018	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.57e-05	0.00018	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—IL2—brain cancer	1.55e-05	0.000178	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SPP1—brain cancer	1.53e-05	0.000176	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	1.52e-05	0.000175	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SPP1—brain cancer	1.52e-05	0.000175	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.51e-05	0.000174	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—EGFR—brain cancer	1.5e-05	0.000173	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—EGFR—brain cancer	1.5e-05	0.000172	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—EGFR—brain cancer	1.49e-05	0.000171	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SPP1—brain cancer	1.48e-05	0.00017	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PIK3CG—brain cancer	1.45e-05	0.000167	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—IL2—brain cancer	1.45e-05	0.000167	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—HES1—brain cancer	1.45e-05	0.000167	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—IL2—brain cancer	1.45e-05	0.000166	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—EGFR—brain cancer	1.44e-05	0.000165	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—HES1—brain cancer	1.43e-05	0.000164	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—HES1—brain cancer	1.43e-05	0.000164	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.42e-05	0.000163	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—PIK3CG—brain cancer	1.42e-05	0.000163	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—APC—brain cancer	1.42e-05	0.000163	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PIK3CG—brain cancer	1.41e-05	0.000162	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—IL2—brain cancer	1.41e-05	0.000162	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—IL2—brain cancer	1.41e-05	0.000162	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—PIK3CG—brain cancer	1.4e-05	0.000161	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—APC—brain cancer	1.4e-05	0.000161	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—HES1—brain cancer	1.4e-05	0.000161	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.38e-05	0.000159	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.38e-05	0.000159	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IRS2—brain cancer	1.38e-05	0.000159	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ENO2—brain cancer	1.38e-05	0.000159	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—IL2—brain cancer	1.38e-05	0.000159	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IRS2—brain cancer	1.38e-05	0.000158	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.36e-05	0.000156	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.36e-05	0.000156	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.35e-05	0.000156	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—IDH1—brain cancer	1.35e-05	0.000155	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SPP1—brain cancer	1.34e-05	0.000154	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IRS2—brain cancer	1.34e-05	0.000154	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.33e-05	0.000153	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SPP1—brain cancer	1.32e-05	0.000152	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SPP1—brain cancer	1.32e-05	0.000151	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HES1—brain cancer	1.3e-05	0.000149	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—EGFR—brain cancer	1.29e-05	0.000149	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.29e-05	0.000149	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—RELA—brain cancer	1.29e-05	0.000148	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—RELA—brain cancer	1.29e-05	0.000148	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—ERBB2—brain cancer	1.28e-05	0.000147	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—ERBB2—brain cancer	1.28e-05	0.000147	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—TP53—brain cancer	1.28e-05	0.000147	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—RELA—brain cancer	1.28e-05	0.000147	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—IL2—brain cancer	1.28e-05	0.000147	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—EGFR—brain cancer	1.28e-05	0.000147	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—ERBB2—brain cancer	1.27e-05	0.000146	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.26e-05	0.000145	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—IL2—brain cancer	1.26e-05	0.000144	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—IL2—brain cancer	1.25e-05	0.000144	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.24e-05	0.000142	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—RELA—brain cancer	1.23e-05	0.000142	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.23e-05	0.000141	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—ERBB2—brain cancer	1.22e-05	0.000141	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—APC—brain cancer	1.22e-05	0.00014	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.22e-05	0.00014	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—APC—brain cancer	1.21e-05	0.00014	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.21e-05	0.00014	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IRS2—brain cancer	1.21e-05	0.000139	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.2e-05	0.000138	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IRS2—brain cancer	1.19e-05	0.000137	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IRS2—brain cancer	1.19e-05	0.000137	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—APC—brain cancer	1.18e-05	0.000136	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	1.18e-05	0.000136	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.17e-05	0.000134	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IL2—brain cancer	1.16e-05	0.000133	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IL2—brain cancer	1.16e-05	0.000133	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IL2—brain cancer	1.15e-05	0.000132	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PIK3CG—brain cancer	1.15e-05	0.000132	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.14e-05	0.000131	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CCND1—brain cancer	1.13e-05	0.00013	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CCND1—brain cancer	1.13e-05	0.00013	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CCND1—brain cancer	1.12e-05	0.000129	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CTNNB1—brain cancer	1.12e-05	0.000129	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CTNNB1—brain cancer	1.12e-05	0.000129	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.11e-05	0.000128	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.11e-05	0.000128	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IL2—brain cancer	1.11e-05	0.000127	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—RELA—brain cancer	1.11e-05	0.000127	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.11e-05	0.000127	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—ERBB2—brain cancer	1.1e-05	0.000127	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—RELA—brain cancer	1.09e-05	0.000126	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—ERBB2—brain cancer	1.09e-05	0.000125	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.09e-05	0.000125	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CCND1—brain cancer	1.08e-05	0.000124	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.08e-05	0.000124	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—APC—brain cancer	1.07e-05	0.000123	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.07e-05	0.000123	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CTNNB1—brain cancer	1.07e-05	0.000123	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ENO2—brain cancer	1.07e-05	0.000122	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—APC—brain cancer	1.05e-05	0.000121	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	0.000121	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PIK3CG—brain cancer	1.05e-05	0.000121	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—APC—brain cancer	1.05e-05	0.000121	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PIK3CG—brain cancer	1.05e-05	0.000121	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PIK3CG—brain cancer	1.05e-05	0.000121	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—APC—brain cancer	1.03e-05	0.000119	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.03e-05	0.000119	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IL2—brain cancer	9.99e-06	0.000115	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—VEGFA—brain cancer	9.86e-06	0.000113	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IL2—brain cancer	9.86e-06	0.000113	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—VEGFA—brain cancer	9.85e-06	0.000113	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—VEGFA—brain cancer	9.79e-06	0.000112	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—STAT3—brain cancer	9.77e-06	0.000112	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—EGFR—brain cancer	9.77e-06	0.000112	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—STAT3—brain cancer	9.76e-06	0.000112	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CCND1—brain cancer	9.74e-06	0.000112	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—STAT3—brain cancer	9.69e-06	0.000111	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CTNNB1—brain cancer	9.65e-06	0.000111	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CCND1—brain cancer	9.61e-06	0.00011	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—EGFR—brain cancer	9.61e-06	0.00011	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	9.6e-06	0.00011	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—APC—brain cancer	9.6e-06	0.00011	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—EGFR—brain cancer	9.59e-06	0.00011	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—RELA—brain cancer	9.54e-06	0.00011	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CTNNB1—brain cancer	9.52e-06	0.000109	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—RELA—brain cancer	9.49e-06	0.000109	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—ERBB2—brain cancer	9.48e-06	0.000109	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—VEGFA—brain cancer	9.43e-06	0.000108	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—ERBB2—brain cancer	9.43e-06	0.000108	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—EGFR—brain cancer	9.41e-06	0.000108	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—STAT3—brain cancer	9.34e-06	0.000107	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—RELA—brain cancer	9.23e-06	0.000106	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—ERBB2—brain cancer	9.17e-06	0.000105	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MYC—brain cancer	9.08e-06	0.000104	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MYC—brain cancer	9.07e-06	0.000104	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MYC—brain cancer	9.01e-06	0.000103	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—EGFR—brain cancer	8.88e-06	0.000102	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—EGFR—brain cancer	8.87e-06	0.000102	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—EGFR—brain cancer	8.81e-06	0.000101	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—EGFR—brain cancer	8.74e-06	0.0001	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MYC—brain cancer	8.68e-06	9.97e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IL2—brain cancer	8.59e-06	9.87e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IL2—brain cancer	8.55e-06	9.82e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VEGFA—brain cancer	8.49e-06	9.75e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EGFR—brain cancer	8.49e-06	9.75e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—STAT3—brain cancer	8.41e-06	9.66e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VEGFA—brain cancer	8.38e-06	9.62e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—RELA—brain cancer	8.38e-06	9.62e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCND1—brain cancer	8.38e-06	9.62e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCND1—brain cancer	8.33e-06	9.57e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—ERBB2—brain cancer	8.32e-06	9.56e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IL2—brain cancer	8.31e-06	9.55e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—STAT3—brain cancer	8.3e-06	9.53e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CTNNB1—brain cancer	8.29e-06	9.53e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CTNNB1—brain cancer	8.25e-06	9.48e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—RELA—brain cancer	8.24e-06	9.47e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RELA—brain cancer	8.22e-06	9.45e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—ERBB2—brain cancer	8.19e-06	9.41e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—ERBB2—brain cancer	8.17e-06	9.39e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCND1—brain cancer	8.1e-06	9.31e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RELA—brain cancer	8.07e-06	9.27e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	8.03e-06	9.22e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—ERBB2—brain cancer	8.02e-06	9.21e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MYC—brain cancer	7.81e-06	8.97e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MYC—brain cancer	7.71e-06	8.85e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EGFR—brain cancer	7.64e-06	8.78e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL2—brain cancer	7.54e-06	8.67e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EGFR—brain cancer	7.54e-06	8.66e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RELA—brain cancer	7.5e-06	8.61e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PIK3CG—brain cancer	7.48e-06	8.59e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TP53—brain cancer	7.45e-06	8.56e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—ERBB2—brain cancer	7.45e-06	8.56e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TP53—brain cancer	7.45e-06	8.55e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL2—brain cancer	7.42e-06	8.53e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL2—brain cancer	7.41e-06	8.51e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TP53—brain cancer	7.4e-06	8.5e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCND1—brain cancer	7.35e-06	8.45e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VEGFA—brain cancer	7.3e-06	8.39e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CTNNB1—brain cancer	7.28e-06	8.37e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL2—brain cancer	7.27e-06	8.35e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VEGFA—brain cancer	7.26e-06	8.34e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCND1—brain cancer	7.24e-06	8.31e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—STAT3—brain cancer	7.23e-06	8.3e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCND1—brain cancer	7.22e-06	8.29e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—STAT3—brain cancer	7.19e-06	8.26e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CTNNB1—brain cancer	7.17e-06	8.23e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CTNNB1—brain cancer	7.15e-06	8.21e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TP53—brain cancer	7.13e-06	8.19e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCND1—brain cancer	7.09e-06	8.14e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VEGFA—brain cancer	7.07e-06	8.12e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	7.02e-06	8.06e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—STAT3—brain cancer	7e-06	8.04e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL2—brain cancer	6.75e-06	7.76e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MYC—brain cancer	6.72e-06	7.72e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MYC—brain cancer	6.68e-06	7.68e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCND1—brain cancer	6.58e-06	7.56e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EGFR—brain cancer	6.57e-06	7.55e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EGFR—brain cancer	6.54e-06	7.51e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	6.52e-06	7.49e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MYC—brain cancer	6.5e-06	7.47e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TP53—brain cancer	6.42e-06	7.37e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VEGFA—brain cancer	6.41e-06	7.36e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EGFR—brain cancer	6.36e-06	7.3e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—STAT3—brain cancer	6.35e-06	7.29e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PIK3CG—brain cancer	6.34e-06	7.28e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TP53—brain cancer	6.33e-06	7.27e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VEGFA—brain cancer	6.31e-06	7.25e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VEGFA—brain cancer	6.29e-06	7.23e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—STAT3—brain cancer	6.25e-06	7.17e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—STAT3—brain cancer	6.23e-06	7.16e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VEGFA—brain cancer	6.18e-06	7.09e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—STAT3—brain cancer	6.12e-06	7.03e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MYC—brain cancer	5.9e-06	6.78e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MYC—brain cancer	5.8e-06	6.67e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MYC—brain cancer	5.79e-06	6.65e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EGFR—brain cancer	5.77e-06	6.63e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VEGFA—brain cancer	5.74e-06	6.59e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MYC—brain cancer	5.68e-06	6.53e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—STAT3—brain cancer	5.68e-06	6.53e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EGFR—brain cancer	5.68e-06	6.52e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EGFR—brain cancer	5.66e-06	6.51e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EGFR—brain cancer	5.56e-06	6.38e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TP53—brain cancer	5.52e-06	6.34e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TP53—brain cancer	5.49e-06	6.3e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TP53—brain cancer	5.34e-06	6.13e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MYC—brain cancer	5.28e-06	6.07e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EGFR—brain cancer	5.16e-06	5.93e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PIK3CG—brain cancer	4.89e-06	5.62e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TP53—brain cancer	4.84e-06	5.56e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TP53—brain cancer	4.77e-06	5.48e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TP53—brain cancer	4.76e-06	5.46e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TP53—brain cancer	4.67e-06	5.36e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TP53—brain cancer	4.34e-06	4.98e-05	CbGpPWpGaD
